202 related articles for article (PubMed ID: 27185624)
21. Oseltamivir-resistant influenza A(H1N1)pdm09 virus associated with high case fatality, India 2015.
Tandel K; Sharma S; Dash PK; Parida M
J Med Virol; 2018 May; 90(5):836-843. PubMed ID: 29288584
[TBL] [Abstract][Full Text] [Related]
22. Influenza A(H1N1)pdm09 virus exhibiting enhanced cross-resistance to oseltamivir and peramivir due to a dual H275Y/G147R substitution, Japan, March 2016.
Takashita E; Fujisaki S; Shirakura M; Nakamura K; Kishida N; Kuwahara T; Shimazu Y; Shimomura T; Watanabe S; Odagiri T;
Euro Surveill; 2016 Jun; 21(24):. PubMed ID: 27336226
[TBL] [Abstract][Full Text] [Related]
23. Role of permissive neuraminidase mutations in influenza A/Brisbane/59/2007-like (H1N1) viruses.
Abed Y; Pizzorno A; Bouhy X; Boivin G
PLoS Pathog; 2011 Dec; 7(12):e1002431. PubMed ID: 22174688
[TBL] [Abstract][Full Text] [Related]
24. Effect of the neuraminidase mutation H274Y conferring resistance to oseltamivir on the replicative capacity and virulence of old and recent human influenza A(H1N1) viruses.
Baz M; Abed Y; Simon P; Hamelin ME; Boivin G
J Infect Dis; 2010 Mar; 201(5):740-5. PubMed ID: 20100088
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of recombinant 2009 pandemic influenza A (H1N1) viruses harboring zanamivir resistance mutations in mice and ferrets.
Pizzorno A; Abed Y; Rhéaume C; Bouhy X; Boivin G
Antimicrob Agents Chemother; 2013 Apr; 57(4):1784-9. PubMed ID: 23357777
[TBL] [Abstract][Full Text] [Related]
26. Analysis of influenza viruses from patients clinically suspected of infection with an oseltamivir resistant virus during the 2009 pandemic in the United States.
Nguyen HT; Trujillo AA; Sheu TG; Levine M; Mishin VP; Shaw M; Ades EW; Klimov AI; Fry AM; Gubareva LV
Antiviral Res; 2012 Mar; 93(3):381-6. PubMed ID: 22330888
[TBL] [Abstract][Full Text] [Related]
27. Pandemic 2009 H1N1 influenza A virus carrying a Q136K mutation in the neuraminidase gene is resistant to zanamivir but exhibits reduced fitness in the guinea pig transmission model.
Kaminski MM; Ohnemus A; Staeheli P; Rubbenstroth D
J Virol; 2013 Feb; 87(3):1912-5. PubMed ID: 23192869
[TBL] [Abstract][Full Text] [Related]
28. Impact of the Baloxavir-Resistant Polymerase Acid I38T Substitution on the Fitness of Contemporary Influenza A(H1N1)pdm09 and A(H3N2) Strains.
Checkmahomed L; M'hamdi Z; Carbonneau J; Venable MC; Baz M; Abed Y; Boivin G
J Infect Dis; 2020 Jan; 221(1):63-70. PubMed ID: 31419295
[TBL] [Abstract][Full Text] [Related]
29. Characteristics of oseltamivir-resistant influenza A (H1N1) pdm09 virus during the 2013-2014 influenza season in Mainland China.
Huang W; Li X; Cheng Y; Tan M; Guo J; Wei H; Zhao X; Lan Y; Xiao N; Wang Z; Wang D; Shu Y
Virol J; 2015 Jun; 12():96. PubMed ID: 26103966
[TBL] [Abstract][Full Text] [Related]
30. Susceptibility of Brazilian influenza A(H1N1)pdm09 viruses to neuraminidase inhibitors in the 2014-2016 seasons: Identification of strains bearing mutations associated with reduced inhibition profile.
Matos AR; Resende PC; Miranda MD; Garcia CC; Caetano BC; Lopes JCO; Debur MC; Cury ALF; Vianna LA; Lima MC; Schirmer M; Gubareva L; Hurt AC; Brown DW; Siqueira MM
Antiviral Res; 2018 Jun; 154():35-43. PubMed ID: 29601892
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic activity of intramuscular peramivir in mice infected with a recombinant influenza A/WSN/33 (H1N1) virus containing the H275Y neuraminidase mutation.
Abed Y; Pizzorno A; Boivin G
Antimicrob Agents Chemother; 2012 Aug; 56(8):4375-80. PubMed ID: 22664977
[TBL] [Abstract][Full Text] [Related]
32. Oseltamivir-zanamivir combination therapy is not superior to zanamivir monotherapy in mice infected with influenza A(H3N2) and A(H1N1)pdm09 viruses.
Pizzorno A; Abed Y; Rhéaume C; Boivin G
Antiviral Res; 2014 May; 105():54-8. PubMed ID: 24583158
[TBL] [Abstract][Full Text] [Related]
33. Comprehensive assessment of 2009 pandemic influenza A (H1N1) virus drug susceptibility in vitro.
Gubareva LV; Trujillo AA; Okomo-Adhiambo M; Mishin VP; Deyde VM; Sleeman K; Nguyen HT; Sheu TG; Garten RJ; Shaw MW; Fry AM; Klimov AI
Antivir Ther; 2010; 15(8):1151-9. PubMed ID: 21149922
[TBL] [Abstract][Full Text] [Related]
34. Impact of neuraminidase mutations conferring influenza resistance to neuraminidase inhibitors in the N1 and N2 genetic backgrounds.
Abed Y; Baz M; Boivin G
Antivir Ther; 2006; 11(8):971-6. PubMed ID: 17302366
[TBL] [Abstract][Full Text] [Related]
35. Generation and characterization of recombinant pandemic influenza A(H1N1) viruses resistant to neuraminidase inhibitors.
Pizzorno A; Bouhy X; Abed Y; Boivin G
J Infect Dis; 2011 Jan; 203(1):25-31. PubMed ID: 21148493
[TBL] [Abstract][Full Text] [Related]
36. Rapid detection of the S247N neuraminidase mutation in influenza A(H1N1)pdm09 virus by one-step duplex RT-PCR assay.
Takayama I; Nakauchi M; Fujisaki S; Odagiri T; Tashiro M; Kageyama T
J Virol Methods; 2013 Mar; 188(1-2):73-5. PubMed ID: 23261798
[TBL] [Abstract][Full Text] [Related]
37. Antiviral susceptibility profile of influenza A viruses; keep an eye on immunocompromised patients under prolonged treatment.
Kossyvakis A; Mentis AA; Tryfinopoulou K; Pogka V; Kalliaropoulos A; Antalis E; Lytras T; Meijer A; Tsiodras S; Karakitsos P; Mentis AF
Eur J Clin Microbiol Infect Dis; 2017 Feb; 36(2):361-371. PubMed ID: 27848039
[TBL] [Abstract][Full Text] [Related]
38. Host cell selection of influenza neuraminidase variants: implications for drug resistance monitoring in A(H1N1) viruses.
Okomo-Adhiambo M; Nguyen HT; Sleeman K; Sheu TG; Deyde VM; Garten RJ; Xu X; Shaw MW; Klimov AI; Gubareva LV
Antiviral Res; 2010 Feb; 85(2):381-8. PubMed ID: 19917319
[TBL] [Abstract][Full Text] [Related]
39. Source of oseltamivir resistance due to single E119D and double E119D/H274Y mutations in pdm09H1N1 influenza neuraminidase.
Hanpaibool C; Leelawiwat M; Takahashi K; Rungrotmongkol T
J Comput Aided Mol Des; 2020 Jan; 34(1):27-37. PubMed ID: 31773463
[TBL] [Abstract][Full Text] [Related]
40. Characterization of drug-resistant recombinant influenza A/H1N1 viruses selected in vitro with peramivir and zanamivir.
Baz M; Abed Y; Boivin G
Antiviral Res; 2007 May; 74(2):159-62. PubMed ID: 17137644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
